EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Study on the dependence potential of (+)-5-oxo-D-prolinepiperidinamide monohydrate (NS-105) in rhesus monkeys and rats


Oyo Yakuri 55(2-3): 61-69
Study on the dependence potential of (+)-5-oxo-D-prolinepiperidinamide monohydrate (NS-105) in rhesus monkeys and rats
The dependence potential of (+)-5-OXO-D-prolinepiperidinamide monohydrate (NS-105) was assessed by four experiments in rhesus monkeys and rats. In gross behavioral observation for acute CNS effects with intravenous administration of NS-105 up to 128 mg/kg in 3 monkeys per dose, no specific effects were observed. In intravenous self-administration of NS-105 at 1, 4 and 16 mg/kg/infusion in 4 monkeys, no active intake was observed.


Accession: 009481571



Related references

Study on the dependence potential of -5-oxo-D-prolinepiperidinamide monohydrate in rhesus monkeys and rats. Oyo Yakuri 55(2-3): 61-69, Feb -March, 1998

Assessment of dependence potential of kjk 945 in rhesus monkeys and rats. Preclinical Reports of the Central Institute for Experimental Animals 13(1): 49-99, 1987

Drug dependence potential of dl 832 tested in rhesus monkeys and rats. Preclinical Reports of the Central Institute for Experimental Animals 8(2): 121-130, 1982

Dependence study on LY170053 in rhesus monkeys and rats. Preclinical Reports of the Central Institute for Experimental Animals 19(2): 73-92, 1993

Dependence study on NK433 in rhesus monkeys and rats. Preclinical Reports of the Central Institute for Experimental Animals 19(3): 173-193, 1993-, 1994

Dependence study on ly 127809 in rhesus monkeys and rats. Preclinical Reports of the Central Institute for Experimental Animals 17(1): 55-81, 1991

Drug dependence study on vigabatrin in rhesus monkeys and rats. Arzneimittel-Forschung 47(10): 1087-1092, 1997

FK960 -p-fluorobenzamide monohydrate, a novel potential antidementia drug, restores the regional cerebral blood flow response abolished by scopolamine but not by HA-966 A positron emission tomography study with unanesthetized rhesus monkeys. Brain Research 832(1-2): 118-123, June 19, 1999

Studies on drug dependence part 30 dependence potential of thebaine in rhesus monkeys. Japanese Journal of Pharmacology 28(SUPPL): 62P, 1978

FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, restores the regional cerebral blood flow response abolished by scopolamine but not by HA-966: a positron emission tomography study with unanesthetized rhesus monkeys. Brain Research 832(1-2): 118-123, 1999